99
December 2, 2025 | 16:32

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW

The most recent episodes of BrainStorm can be found below.
Thank you Genentech, Eisai, and Lundbeck for your support of BrainStorm.

43
July 3, 2023 | 18:52

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

Should Alzheimer’s drugs be treated like all other drugs when it comes to Medicare coverage? The Alliance for Aging Research CEO Sue Peschin and BrainStorm

LISTEN NOW
42
June 20, 2023 | 17:45

John Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs

Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke

LISTEN NOW
41
June 6, 2023 | 12:37

Amy Dockser Marcus, Author of "We the Scientists" (part 2)

We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine

In Part 2 of the interview with

LISTEN NOW
40
May 16, 2023 | 24:58

Amy Dockser Marcus, Author of "We the Scientists" (part 1)

We the Scientists: How a Daring Team of Parents and Doctors Forged A New Path for Medicine

Pulitzer Prize winning Wall Street Reporter Amy Marcus, in

LISTEN NOW
39
May 2, 2023 | 18:32

Sandra Bond Chapman, PhD and the Importance of Lifelong Brain Health (part 2)

Want to improve your brain’s performance? Find out the latest from Dr. Sandra Bond Chapman, Founder and Chief Director of The Center for BrainHealth at

LISTEN NOW